Customized care that
provides consistent dosing

Illustration of CaroSpir boxes and bottles

Avoid the Risks & Inconsistencies of

Crushed/compounded formulations can exhibit a wide variation in potency. The FDA recommends using approved liquid alternatives instead.

CMP Pharma specializes in liquid formulations of branded medications to better serve patients who may be unable to swallow or have difficulty swallowing traditional formulations.

The FDA has recently issued stricter guidance about the use of crushed/compounded products, recommending that drugs not be crushed/compounded if FDA-approved alternatives, such as the branded oral liquids offered by CMP Pharma exist.

Learn more about the risks of crushing/compounding here.


Norliqva is the first FDA-approved liquid solution of amlodipine for the treatment of hypertension for patients 6 and older who are unable or who have trouble swallowing.


The first and only FDA-approved oral suspension of spironolactone, providing a stable, ready to use, and consistent liquid for adult patients who have difficulty swallowing, or who cannot swallow, tablets.

Illustration of a CaroSpir bottle


Indications And Usage

CAROSPIR is an antagonist of aldosterone indicated for:

  • the treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hospitalization for heart failure
  • use as an add-on therapy for the treatment of hypertension, to lower blood pressure in adult patients. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions
  • the management of edema in adult cirrhotic patients when edema is not responsive to fluid and sodium restrictions


CAROSPIR® is contraindicated for patients with the following conditions: Hyperkalemia, Addison’s disease, Concomitant use of eplerenone